Bloomage BioTechnology Corporation Limited (SHA:688363)
China
· Delayed Price · Currency is CNY 43.35
+0.11 (0.25%)
Apr 29, 2026, 3:00 PM CST
SHA:688363 Revenue
In the year 2025, Bloomage BioTechnology Corporation had annual revenue of 4.20B CNY, down -21.82%. Bloomage BioTechnology Corporation had revenue of 1.04B in the quarter ending December 31, 2025, a decrease of -30.77%.
Revenue
4.20B
Revenue Growth
-21.82%
P/S Ratio
4.93
Revenue / Employee
944.89K
Employees
3,860
Market Cap
20.68B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.20B | -1.17B | -21.82% |
| Dec 31, 2024 | 5.37B | -705.15M | -11.61% |
| Dec 31, 2023 | 6.08B | -283.27M | -4.45% |
| Dec 31, 2022 | 6.36B | 1.41B | 28.53% |
| Dec 31, 2021 | 4.95B | 2.32B | 87.93% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sanxiang Advanced Materials | 1.20B |
| Guangdong Dowstone Technology | 8.63B |
| Jinhong Gas | 2.78B |
| Zhejiang Jiemei Electronic And Technology | 2.19B |
| Novoray | 1.17B |
| Guangdong Huate Gas | 1.42B |
| Anhui Shenjian New Materials Co.,Ltd | 2.39B |
| Zibo Qixiang Tengda Chemical | 24.05B |